Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
- PMID: 31469443
- DOI: 10.1111/nyas.14223
Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
Abstract
Carbapenem-resistant Enterobacteriaceae (CRE) have been listed by the WHO as high-priority pathogens owing to their high association with mortalities and morbidities. Resistance to multiple β-lactams complicates effective clinical management of CRE infections. Using plasmid typing methods, a wide distribution of plasmid replicon groups has been reported in CREs around the world, including IncF, N, X, A/C, L/M, R, P, H, I, and W. We performed a literature search for English research papers, published between 2013 and 2018, reporting on plasmid-mediated carbapenem resistance. A rise in both carbapenemase types and associated plasmid replicon groups was seen, with China, Canada, and the United States recording a higher increase than other countries. blaKPC was the most prevalent, except in Angola and the Czech Republic, where OXA-181 (n = 50, 88%) and OXA-48-like (n = 24, 44%) carbapenemases were most prevalent, respectively; blaKPC-2/3 accounted for 70% (n = 956) of all reported carbapenemases. IncF plasmids were found to be responsible for disseminating different antibiotic resistance genes worldwide, accounting for almost 40% (n = 254) of plasmid-borne carbapenemases. blaCTX-M , blaTEM , blaSHV , blaOXA-1/9 , qnr, and aac-(6')-lb were mostly detected concurrently with carbapenemases. Most reported plasmids were conjugative but not present in multiple countries or species, suggesting limited interspecies and interboundary transmission of a common plasmid. A major limitation to effective characterization of plasmid evolution was the use of PCR-based instead of whole-plasmid sequencing-based plasmid typing.
Keywords: CRE; carbapenem resistance; incompatibility groups; plasmid typing; replicon types.
© 2019 New York Academy of Sciences.
References
-
- Cai, B. et al. 2017. Prevalence of carbapenem-resistant Gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect. Dis. 4. https://doi.org/10.1093/ofid/ofx176.
-
- Buehrle, D.J. et al. 2017. Carbapenem-resistant Pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob. Agents Chemother. 61. https://doi.org/10.1128/AAC.01243-16.
-
- Livorsi, D.J. et al. 2018. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob. Resist. Infect. Control 7: 55.
-
- Patel, G., S. Huprikar & S.H. Factor. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29: 1099-1106.
-
- Zhang, Y. et al. 2016. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies. Emerg. Microbes Infect. 5: e27.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical